799 Combination intraperitoneal chemoimmunotherapy triggers a T-cell chemotactic locoregional response in patients with recurrent platinum-sensitive ovarian cancer

• Lixin Zhang,
• Robert Edwards,
• Mary Strange,
• Anda Vlad,
• Syed Zaidi,
• Mackenzy Radolec,
• Brian Orr

Affiliations

Lixin Zhang

3Magee-Womens Research Institute, Pittsburgh, PA, USA

Robert Edwards

4Magee Women’s Hospital of UPMC, Pittsburgh, PA, USA

Mary Strange

3Magee-Womens Research Institute, Pittsburgh, PA, USA

Anda Vlad

2University of Pittsburgh, Pittsburgh, PA, USA

Syed Zaidi

3Magee-Womens Research Institute, Pittsburgh, PA, USA

Mackenzy Radolec

1University of Pittsburgh Medical Center, Pittsburgh, PA, USA

Brian Orr

2University of Pittsburgh, Pittsburgh, PA, USA